Wheatley Margaret A, Forsberg Flemming, Dube Neal, Patel Mihir, Oeffinger Brian E
School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, USA.
Ultrasound Med Biol. 2006 Jan;32(1):83-93. doi: 10.1016/j.ultrasmedbio.2005.08.009.
Ultrasound contrast agents (CA) are generally micron-sized stabilized gas bubbles, injected IV. However, to penetrate beyond the vasculature and accumulate in targets such as tumors, CA must be an order of magnitude smaller. We describe a method of achieving nanometer-sized, surfactant-stabilized CA by differential centrifugation. High g force was shown to destroy bubble integrity. Optimal conditions (300 rpm for 3 min) produced an agent with a mean diameter of 450 nm, which gave 25.5 dB enhancement in vitro at a dose of 10 microL/mL, with a 13 min half-life. In vivo, the CA produced excellent power Doppler and grey-scale pulse inversion harmonic images at low acoustic power when administered. In vivo dose-response curves obtained in three rabbits showed enhancement between 20 and 25 dB for dosages above 0.025 mL/kg. These results encourage further investigation of the possible diagnostic and therapeutic benefits of using nanoparticles as CA, including passive targeting and accumulation in tumors.
超声造影剂(CA)通常是微米级的稳定气泡,通过静脉注射。然而,为了穿透血管系统并在肿瘤等靶点中积聚,CA必须小一个数量级。我们描述了一种通过差速离心获得纳米级、表面活性剂稳定的CA的方法。高离心力会破坏气泡完整性。最佳条件(300转/分钟,持续3分钟)产生的造影剂平均直径为450纳米,在剂量为10微升/毫升时,体外增强效果为25.5分贝,半衰期为13分钟。在体内,给药时,该造影剂在低声功率下产生了出色的功率多普勒和灰阶脉冲反转谐波图像。在三只兔子身上获得的体内剂量反应曲线显示,剂量高于0.025毫升/千克时,增强效果在20至25分贝之间。这些结果鼓励进一步研究将纳米颗粒用作造影剂可能带来的诊断和治疗益处,包括被动靶向和在肿瘤中的积聚。